Trade GOSS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Gossamer Bio, Inc. (GOSS) is trading at US$0.17, down 1.82% today as of Aug 28, 13:57 EDT. The company has a market capitalisation of US$75.62M. Over the past 52 weeks, GOSS has traded between US$0.11 and US$3.87. On Syfe you can trade GOSS with $0 commission and add it to your watchlist.
| Previous close | US$0.17 |
|---|---|
| Market cap | US$75.62M |
| 52-week range | US$0.11 – US$3.87 |
| Volume | 15.28M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Gossamer Bio, Inc.
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.
Year: 2019
Leerink Partners Upgrades Gossamer Bio to Outperform From Market Perform, $1 Price Target
Jul 28, 11:25 AM · MT Newswires
Top Premarket Gainers
Jul 28, 11:09 AM · MT Newswires
Update: Gossamer Bio Extends Gains Pre-Bell Following New Drug Application Filing Plans for Pulmonary Arterial Hypertension Treatment
Jul 28, 8:19 AM · MT Newswires
Gossamer Bio, Inc. (GOSS) stock is trading at US$0.17, -1.82% from the previous close of US$0.17.
The market cap for Gossamer Bio, Inc. (GOSS) stock is approximately US$75.62M.
The 52-week high for Gossamer Bio, Inc. (GOSS) stock is US$3.87.
The 52-week low for Gossamer Bio, Inc. (GOSS) stock is US$0.11.
Gossamer Bio, Inc. (GOSS) does not currently pay a dividend.
Stay on top of GOSS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
